Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Rund, 1998)
Unfortunately, many people interested in using treatments like GLP-1, GLP-1/GIP, or Triple G don't qualify for insurance coverage, meaning they could end up paying more than $1,000 a month out of pocket
Wegovy (semaglutide) is a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones
Participants who combined the medication with exercise did not experience bone density loss, unlike those who took the medication without exercising
Pricing typically starts around $159 per month for compounded semaglutide and can increase depending on dosage or medication type
In the UK, NICE recommends GLP-1 receptor agonists for type 2 diabetes in specific circumstances (NG28), such as when metformin is insufficient and BMI 30 kg/m
